DHG Pharmaceutical JSC - Asset Resilience Ratio

Latest as of June 2026: 30.97%

DHG Pharmaceutical JSC (DHG) has an Asset Resilience Ratio of 30.97% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See DHG net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₫1.55 Trillion
≈ $58.89 Million USD Cash + Short-term Investments

Total Assets

₫5.01 Trillion
≈ $190.18 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how DHG Pharmaceutical JSC's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see DHG total asset value.

Liquid Assets Composition Over Time

This chart breaks down DHG Pharmaceutical JSC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read DHG liabilities breakdown for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₫0.00 0%
Short-term Investments ₫1.55 Trillion 30.97%
Total Liquid Assets ₫1.55 Trillion 30.97%

Asset Resilience Insights

  • Very High Liquidity: DHG Pharmaceutical JSC maintains exceptional liquid asset reserves at 30.97% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

DHG Pharmaceutical JSC Industry Peers by Asset Resilience Ratio

Compare DHG Pharmaceutical JSC's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM
Drug Manufacturers - Specialty & Generic 2.79%
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Beijing Tongrentang Co Ltd
SHG:600085
Drug Manufacturers - Specialty & Generic 2.51%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
Drug Manufacturers - Specialty & Generic 20.44%
Harbin Pharmaceutical Group Co Ltd
SHG:600664
Drug Manufacturers - Specialty & Generic 0.97%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%

Annual Asset Resilience Ratio for DHG Pharmaceutical JSC (2019–2025)

The table below shows the annual Asset Resilience Ratio data for DHG Pharmaceutical JSC.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 39.18% ₫2.02 Trillion
≈ $76.90 Million
₫5.17 Trillion
≈ $196.27 Million
-6.88pp
2024-12-31 46.06% ₫2.75 Trillion
≈ $104.29 Million
₫5.96 Trillion
≈ $226.41 Million
+9.57pp
2023-12-31 36.49% ₫2.23 Trillion
≈ $84.73 Million
₫6.11 Trillion
≈ $232.16 Million
-9.07pp
2022-12-31 45.57% ₫2.35 Trillion
≈ $89.48 Million
₫5.17 Trillion
≈ $196.36 Million
-0.13pp
2021-12-31 45.69% ₫2.11 Trillion
≈ $80.17 Million
₫4.62 Trillion
≈ $175.44 Million
-0.94pp
2020-12-31 46.63% ₫2.07 Trillion
≈ $78.80 Million
₫4.45 Trillion
≈ $168.98 Million
+4.00pp
2019-12-31 42.64% ₫1.77 Trillion
≈ $67.17 Million
₫4.15 Trillion
≈ $157.55 Million
--
pp = percentage points

About DHG Pharmaceutical JSC

VN:DHG Vietnam Drug Manufacturers - Specialty & Generic
Market Cap
$449.56 Million
₫11.83 Trillion VND
Market Cap Rank
#12982 Global
#58 in Vietnam
Share Price
₫90500.00
Change (1 day)
+0.00%
52-Week Range
₫90000.00 - ₫108100.00
All Time High
₫130801.51
About

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, dermatology, and beauty care products. It also manufactures and … Read more